NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ)
$0.059 -0.011 (-15.7143%)
Analysed NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) News Sources
NeuroSense Therapeutics Receives Japanese Patent Grant for PrimeC Novel Composition
09-06-2026
yahoo.com
NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS
11-06-2026
yahoo.com
NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease
25-06-2026
yahoo.com
NeuroSense Achieves Primary Endpoint in Phase 2b ALS Study with Statistically Significant Reduction of TDP-43, the Defining Pathological Hallmark of ALS
29-06-2026
yahoo.com
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
06-07-2026
yahoo.com
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
22-07-2026
yahoo.com
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
06-08-2026
yahoo.com
NeuroSense Issues CEO Letter to Shareholders
13-08-2026
yahoo.com
NeuroSense Unveils Accelerated, Capital-Efficient Strategy to Advance PrimeC Toward Potential Approval in ALS
31-08-2026
yahoo.com
EverythingALS to Host NeuroSense in a Community Event Named: PrimeC - Connecting the Dots
22-06-2026
yahoo.com
What is the current price of NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ)?
The current price of NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) is $0.059.
NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) since the previous trading day is $-0.011.
NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) since the previous trading day is -15.7143%.
What is the most recent average sentiment score for NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ)?
The most recent average sentiment score for NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ)?
The most recent sentiment for NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ) is .
SEC-8K** Filing Available For NEUROSENSE THERAPEUTI -CW23 (NRSNW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.